ECE2018 Poster Presentations: Pituitary and Neuroendocrinology Pituitary - Clinical (101 abstracts)
Optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas
Jung Hee Kim 1, , Yun-Sik Dho 2, , Yong Hwy Kim 2, , Jung Hyun Lee 2, , Ji Hyun Lee 1 , A. Ram Hong 1 , Min Kyong Moon 1 & Chan Soo Shin 1,
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Pituitary Center, Seoul National University Hospital, Seoul, Republic of Korea; 3Department of
Neurosurgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Object: The natural history and proper algorithm for follow-up testing of nonfunctioning pituitary adenomas (NFPAs) are not well known, despite their relatively high prevalence. The aim of this study was to suggest the optimal follow-up algorithm for NFPAs, based on the natural history.
Methods: We followed up on 197 patients with NFPAs without any treatment (including surgery and radiation) at the time of detection, in a single center, between March 2000 and February 2017. We conducted a hormone test, visual field test and magnetic resonance imaging (MRI) at the time of diagnosis, and then, yearly.
Results: The overall median follow-up duration was 37 months. Microadenomas (n=38) did not cause visual disturbance, pituitary apoplexy, or endocrine dysfunction. The incidence of patents with a 120% or larger tumor volume growth was higher in macroadenomas than microadenomas (13.8% vs. 5.0% per year). The overall incidence rate of worsening visual function was 0.69% per year. Patients with a tumor volume growth rate ≥ 0.35 cm3/year (n=38) showed higher incidences of worsening visual functions (3.52% vs. 0.16% per year) and endocrine dysfunction (4.40% vs. 0.49% per year). Based on the tumor volume growth rate, the median time for 10% of patients to grow more than 120% was 3.4 years in microadenomas and 1.9 years in macroadenomas.
Conclusion: The tumor volume growth rate was the strongest predictor of worsening visual functions or endocrine dysfunction. A follow-up strategy needed to be determined based on the tumor volume growth rate as well as initial tumor volume.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more